Supplementary Table 3.
Risk factors for long-term mortality in patients unfit for chemotherapy who underwent EUS-HGS as best supportive care
| Long-term mortality after EUS-hepaticogastrostomy | ||||
|---|---|---|---|---|
|
| ||||
| Univariate (Exp (b) [95% C.I.]) | P | Multivariate (Exp (b) [95% C.I.]) | P | |
| Gender (male) | NS | NS | - | - |
| Age | NS | NS | - | - |
| Study period (2018-2020) | NS | NS | - | - |
| Bismuth-Corlette classification | NS | NS | - | - |
| Distant metastasis | NS | NS | - | - |
| Ascites | NS | NS | - | - |
| Basal bilirubin levels | NS | NS | - | - |
| Indication for biliary drainage | NS | NS | - | - |
| Clinical success | 0.17 [0.03-0. 90] | 0.04 | 0.17 [0.03-0. 90] | 0.04 |
| Type of stent | NS | NS | - | - |
| Adverse event | NS | NS | - | - |
| Stent dysfunction | NS | NS | - | - |
| Need for reintervention | NS | NS | - | - |
95% C.I.: 95% confidence interval, NS: Not statistically significant